Neurotrophic Keratitis Market Players:
- Dompe Farmaceutici SpA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Oyster Point Pharma, Inc.
- Neuroptica, Inc.
- Recordati Rare Diseases
- KALA BIO
- ReGenTree, LLC
- BRIM Biotechnology, Inc.
- Bausch + Lomb Incorporated
- Oculis
- HLB Therapeutics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of neurotrophic keratitis is assessed at USD 396.04 million.
The global neurotrophic keratitis market size surpassed USD 371 million in 2025 and is projected to grow at a CAGR of more than 7.5%, reaching USD 764.64 million revenue by 2035.
North America neurotrophic keratitis market attains a 32% share by 2035, driven by the dominance of large players and increasing new product launches in the region.
Key players in the market include Dompe Farmaceutici SpA, Oyster Point Pharma, Inc., Neuroptica, Inc., Recordati Rare Diseases, KALA BIO, ReGenTree, LLC, BRIM Biotechnology, Inc., Bausch + Lomb Incorporated, Oculis, HLB Therapeutics.
